BRK.B vs BSX · rev $371.44B vs P/E 20, rev $10.65B
BRK.B (BRK.B) versus Boston Scientific Corp (BSX) — a side-by-side from cached financials, not a winner call.
BRK.B (BRK.B) common stock. It is led by Warren Buffett.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Latest reported BRK.B revenue for 2025-12-31 was $371.44B. Net income was $66.97B. Revenue was up 616.8% from 2015-12-31 to 2025-12-31. BRK.B currently screens at market cap $0.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
BRK.B currently screens at market cap $0. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Not investment advice. Open the BRK.B and BSX stock pages for the full models.
Not investment advice.